Performance Testing in Young Soccer Players

June 28, 2020 updated by: Ioannis G. Fatouros, University of Thessaly

Evaluation of Soccer-specific Performance and Body Composition in Youth Soccer Players of Different Age Groups

The aim of this study is to investigate physiological characteristics, body composition and performance indicators among youth soccer players of four age categories (U-12, U-14, U-16, and U-18). Participants will undergo assessment of their body weight, body height and percent of body fat as well as performance testing including flexibility, strength, vertical jump, speed, repeated sprint ability, agility, dribbling and endurance.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Unknown

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This study aims at investigating anthropometric, body composition and performance indicators among male youth soccer players. The study will be conducted prior to the preparation period. Initially, participants and their parents (for those under 18 years) will be informed about the benefits, risks and discomforts associated with the study and will provide a written consent. Participants will be instructed to refrain from strenuous exercise for at least 48 hours prior to testing and they will be also asked to consume their normal diet. Prior to testing all participants will be familiarized with testing procedures and specific test. Body weight will be measured on a seca beam balance. Participants' height will be measured by using a fixed stadiometer and the percent body fat will be calculated with bioelectrical impedance analysis. Flexibility will be assessed by using the sit and reach test and the lower body explosive strength will be determined through vertical jump testing (squat jump and counter movement jump without arm swing). Knee flexor and extensor strength will be assessed on an isokinetic dynamometer. Sprint performance will be assessed from a standing start over by infrared photocells with participants running 10m and 30m as fast as they can. The repeated sprint ability will be tested by using linear sprint test including 5 maximum sprints of 30 meters with a 25-second recovery period in-between. Maximal oxygen consumption (VO2max) will be determined by open-circuit spirometry via breath-by-breath analysis during a graded exercise test to exhaustion on a treadmill. Furthermore, participants will be evaluated in agility by using the short dribbling test and the ability to recover after repeated intense exercise through the YO-YO Intermittent Recovery test 1 (only for u-16 and U-18 groups).

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Anticipated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Greece
      • Trikala, Greece, 42100
        • University of Thessaly, School of Physical Education and Sports Science

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

11 years to 18 years (ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

Youth soccer players (aged 11-18 years) participating in regular soccer practice and competition with a training age of ≥ 3 years.

Description

Inclusion Criteria:

  • Aged between 11 and 12 years
  • Active soccer players participating in regular soccer practice and competition
  • Training age ≥ 3 years
  • Free of chronic diseases
  • Free of musculoskeletal injury

Exclusion Criteria:

  • Musculoskeletal injury
  • Chronic disease
  • Training age ≤ 2 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Under-12 (U12) players
Other: Performance testing
Soccer-specific performance will be evaluated by measuring flexibility, jumping ability, maximum speed, repeated spring ability, agility and endurance.
Under-14 (U14) players
Other: Performance testing
Soccer-specific performance will be evaluated by measuring flexibility, jumping ability, maximum speed, repeated spring ability, agility and endurance.
Under-16 (U16) players
Other: Performance testing
Soccer-specific performance will be evaluated by measuring flexibility, jumping ability, maximum speed, repeated spring ability, agility and endurance.
Under-18 (U18) players
Other: Performance testing
Soccer-specific performance will be evaluated by measuring flexibility, jumping ability, maximum speed, repeated spring ability, agility and endurance.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Flexibility
Time Frame: At baseline
Flexibility will be assessed by using the sit-and-reach test
At baseline
Jumping ability
Time Frame: At baseline
Jumping ability will be assessed by measuring the vertical jumping performance using two different techniques: i) countermovement and ii) squat jump.
At baseline
Maximum speed
Time Frame: At baseline
Maximum speed will be assessed over 10 m and 30 m by using light cells
At baseline
Repeated sprint ability
Time Frame: At baseline
Repeated sprint ability will be assessed by performing five 30-m sprints with 25 seconds recovery period in-between, and using light cells.
At baseline
Agility
Time Frame: At baseline
The ability to change direction while dribbling the ball (termed agility) will be assessed by using the short dribbling test (performed according to standard procedures).
At baseline
Endurance
Time Frame: At baseline
Endurance will be assessed by using the Yo-Yo Intermittent Recovery test level 1
At baseline
Maximal oxygen consumption (VO2max)
Time Frame: At baseline
Maximal oxygen consumption will be measured by open-circuit spirometry via breath-by-breath analysis during a graded exercise test to exhaustion on a treadmill, using automated pulmonary gas exchange system.
At baseline
Knee flexor and extensor strength
Time Frame: At baseline
Concentric and eccentric peak torque of knee flexors and extensors in both limbs (dominant and non-dominant) will be assessed on an isokinetic dynamometer
At baseline

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Body height
Time Frame: At baseline
Body height will be measured on a beam balance with stadiometer.
At baseline
Body weight
Time Frame: At baseline
Body weight will be measured on a beam balance with stadiometer.
At baseline
Body composition
Time Frame: At baseline
Body fat and fat-free mass will be estimated by using bioelectrical impedance.
At baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of Thessaly

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Athanasios Poulios, PhD, University of Thessaly

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
August 5, 2020

Primary Completion (ANTICIPATED)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
August 30, 2020

Study Completion (ANTICIPATED)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
September 10, 2020

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
June 24, 2020

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 28, 2020

First Posted (ACTUAL)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
July 2, 2020

Study Record Updates

Last Update Posted (ACTUAL)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
July 2, 2020

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 28, 2020

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2020

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • YOUTH SOCCER STUDY-UTH-2020

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Performance

Clinical Trials on Performance testing

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings